Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15593186rdf:typepubmed:Citationlld:pubmed
pubmed-article:15593186lifeskim:mentionsumls-concept:C1123023lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C0292688lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C0040690lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15593186lifeskim:mentionsumls-concept:C1533157lld:lifeskim
pubmed-article:15593186pubmed:issue12lld:pubmed
pubmed-article:15593186pubmed:dateCreated2004-12-15lld:pubmed
pubmed-article:15593186pubmed:abstractTextMembers of the transforming growth factor beta (TGFbeta) cytokine superfamily play critical roles in both homeostasis and disease. In light of their profibrotic effects, these molecules are implicated in the pathogenesis of fibrosis. In fibroblasts, TGFbeta signals through the activin receptor-like kinase 5 (ALK-5) type I TGFbeta and triggers Smad and MAP kinase signaling pathways. Because targeting of TGFbeta signaling represents a potential approach to the treatment of systemic sclerosis (SSc) and other fibrotic disorders, we investigated the modulation of intracellular TGFbeta signal transduction by SB431542, the first small-molecule inhibitor of ALK-5 to be described.lld:pubmed
pubmed-article:15593186pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:languageenglld:pubmed
pubmed-article:15593186pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15593186pubmed:statusMEDLINElld:pubmed
pubmed-article:15593186pubmed:monthDeclld:pubmed
pubmed-article:15593186pubmed:issn0004-3591lld:pubmed
pubmed-article:15593186pubmed:authorpubmed-author:PlataniasLeon...lld:pubmed
pubmed-article:15593186pubmed:authorpubmed-author:VargaJohnJlld:pubmed
pubmed-article:15593186pubmed:authorpubmed-author:MoriYasujiYlld:pubmed
pubmed-article:15593186pubmed:authorpubmed-author:LiYongzhongYlld:pubmed
pubmed-article:15593186pubmed:authorpubmed-author:Bhattacharyya...lld:pubmed
pubmed-article:15593186pubmed:authorpubmed-author:IshidaWataruWlld:pubmed
pubmed-article:15593186pubmed:issnTypePrintlld:pubmed
pubmed-article:15593186pubmed:volume50lld:pubmed
pubmed-article:15593186pubmed:ownerNLMlld:pubmed
pubmed-article:15593186pubmed:authorsCompleteYlld:pubmed
pubmed-article:15593186pubmed:pagination4008-21lld:pubmed
pubmed-article:15593186pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:meshHeadingpubmed-meshheading:15593186...lld:pubmed
pubmed-article:15593186pubmed:year2004lld:pubmed
pubmed-article:15593186pubmed:articleTitleSelective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.lld:pubmed
pubmed-article:15593186pubmed:affiliationUniversity of Illinois College of Medicine, Chicago.lld:pubmed
pubmed-article:15593186pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15593186pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15593186pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15593186lld:pubmed